SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

May 12, 2016

Date of report (Date of earliest event reported)

 

 

 

BIOLIFE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 Delaware 0-18710 94-3076866
 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.)

 

3303 Monte Villa Parkway, Bothell, WA 98021

(Address of principal executive offices, including zip code)

 

(425) 402-1400

(Registrant’s telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

  

Item 2.02.   Results of Operations and Financial Condition.

 

On May 12, 2016, BioLife Solutions, Inc. (the “Company”) issued a press release announcing financial results of the Company for the first quarter ended March 31, 2016. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.

 

Item 9.01.   Financial Statements and Exhibits.

 

(d)Exhibits

 

Exhibit No.

   Description
     
99.1   Press release dated May 12, 2016

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOLIFE SOLUTIONS, INC.  
       
       
Dated: May 12, 2016 By:   /s/ Roderick de Greef  
    Roderick de Greef  
    Chief Financial Officer  

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.

   Description
     
99.1   Press release dated May 12, 2016